Cytarabine
Chemical Name: 4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
Purity: ≥98%
Biological Activity
Cytarabine is a nucleoside analog of deoxycytidine; inhibits DNA replication by incorporating into DNA (IC50 = 0.04 μM in L1210 and CEM cell lines). Displays no inhibitory effects on RNA synthesis. Causes S phase cell cycle arrest in ML-1 cell lines; cytotoxic in L5817Y leukemia cells. Antineoplastic and antileukemic agent.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Pharmacodynamics of cytar. alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.
Sampath et al.
Blood., 2006;107:2517 -
Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytar. in metastatic and s.c. human tumor xenograft models.
Breistøl et al.
Cancer Res., 1999;59:2944 -
Effect of cytar. upon metabolism of phospholipids in leukemia L5178Y cells.
Yang et al.
Acta Pharmacol. Sin., 1986;7:368
Product Datasheets
Citations for Cytarabine
The citations listed below are publications that use Tocris products. Selected citations for Cytarabine include:
6 Citations: Showing 1 - 6
-
Efficient Derivation of Excitatory and Inhibitory Neurons from Human Pluripotent Stem Cells Stably Expressing Direct Reprogramming Factors.
Authors: Karen Et al.
Curr Protoc 2021;1:e141
-
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG.
Authors: Uwe Et al.
Cancer Discov 2021;11:500-519
-
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine.
Authors: Oliver T Et al.
Commun Biol 2020;3:324
-
Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs.
Authors: Paul A Et al.
Autophagy 2019;15:900-907
-
Systematic analysis of protein turnover in primary cells.
Authors: Mathieson Et al.
Nat Commun 2018;9:689
-
Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.
Authors: Bisikirska Et al.
Cancer Res 2016;76:664
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Cytarabine
There are currently no reviews for this product. Be the first to review Cytarabine and earn rewards!
Have you used Cytarabine?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image